1-4 of 4
Victor Y. Yazbeck
Close
Sort by
Journal Articles

Inhibition of the Pan-Bcl-2 Family by the Small Molecule GX15-070 Induces Apoptosis in Mantle Cell Lymphoma (MCL) Cells and Enhances the Activity of Two Proteasome Inhibitors (NPI-0052 and Bortezomib), and Doxorubicin Chemotherapy.

Victor Y. Yazbeck, MD, Georgios V. Georgakis, M.D., Yang Li, David McConkey, Michael Andreeff, Anas Younes
Journal: Blood
Blood (2006) 108 (11): 2532.
https://doi.org/10.1182/blood.V108.11.2532.2532
Published: 2006
Journal Articles

Molecular Mechanisms of the mTOR Inhibitor Temsirolimus (CCI-779) Antiproliferative Effects in Mantle Cell Lymphoma: Induction of Cell Cycle Arrest, Autophagy, and Synergy with Vorinostat (SAHA).

Victor Y. Yazbeck, MD, Georgios V. Georgakis, M.D., Yang Li, M.S., Eiji Iwado, M.D., Seiji Kondo, M.D./PhD, Anas Younes, M.D.
Journal: Blood
Blood (2006) 108 (11): 2493.
https://doi.org/10.1182/blood.V108.11.2493.2493
Published: 2006
Journal Articles

The mTOR Inhibitor Temsirolimus (CCI-779) Induces Cell Cycle Arrest and Autophagy in Hodgkin Lymphoma (HL) Cell Lines and Enhances the Effect of the PI3-Kinase Inhibitor LY294002.

Georgios V. Georgakis, Victor Y. Yazbeck, Yang Li, Anas Younes, M.D.
Journal: Blood
Blood (2006) 108 (11): 2259.
https://doi.org/10.1182/blood.V108.11.2259.2259
Published: 2006
Journal Articles

The Histone Deacetylase Inhibitor Vorinostat (SAHA) Induces Apoptosis and Cell Cycle Arrest in Hodgkin Lymphoma (HL) Cell Lines by Altering Several Survival Signaling Pathways and Synergizes with Doxorubicin, Gemcitabine and Bortezomib.

Georgios V. Georgakis, MD, Victor Y. Yazbeck, M.D., Yang Li, M.D., Anas Younes, M.D.
Journal: Blood
Blood (2006) 108 (11): 2260.
https://doi.org/10.1182/blood.V108.11.2260.2260
Published: 2006